arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

BeOne Medicines Ltd.

ONC
$387.31 ▲ +9.82 (+2.60%) at close
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
48 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
68
Health
Good
Neutral
auto_awesome

Analytical Summary

BeOne Medicines Ltd. shows mixed fundamentals. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap $561.8B
Dividend Yield —
Revenue Growth 29.6% ↘
Op. Margin 19.1% ↗
ROIC 4.1% ↗
FCF / Share $0.30 ↗
Trailing P/E 2420.7x
Price / Book 110.0x
FCF Yield 0.1%
Debt / Equity 0.17
info Valuation on last close. End-of-day price, Nov 5, 2026.

48-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$1.71B
↑ +29.6% —
Net Income Profit after all expenses
$227.36M
↑ +17802.1% —
Operating Margin Operating profit as % of sales
19.1%
↑ +15.5% 52th
FCF / Share Free cash flow per share
$0.30
↑ +169.7% —
Long-Term Debt Long-term obligations
$788.68M
↓ -6.4% —

Health Breakdown

Profitability
60
Returns
58
Financial Health ↑
77
Cash Quality ↑
92

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 13 years · 48 quarters